MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$427,669K
Cash and cash
equivalents
$77,063K
Gross carrying amount
$69,320K
Total cash, cash
equivalents, and marketable...
$504,732K
Other current assets
$98,103K
Accounts and accrued
receivable
$36,761K
Restricted cash
$25,000K
Property and equipment,
net
$422,806K
Other long-term
assets
$69,136K
Investments in equity
accounted investees
$65,308K
Goodwill
$47,806K
Intangible assets, net
$37,460K
Accumulated amortization
$31,860K
Total current assets
$664,596K
Total long-term
assets
$642,516K
Total assets
$1,307,112K
Total liabilities and
shareholders' equity
$1,307,112K
Total shareholders'
equity
$938,083K
Total liabilities
$369,029K
Accumulated deficit
-$72,647K
Accumulated other
comprehensive loss
-$2,419K
Common shares no par
value, unlimited...
$816,533K
Additional paid-in capital
$196,616K
Total long-term
liabilities
$321,735K
Total current
liabilities
$47,294K
Deferred government
contributions
$176,105K
Operating lease liability
$134,309K
Other long-term
liabilities
$11,321K
Accounts payable and
other current...
$39,551K
Deferred revenue
$7,743K
Back
Back
Balance Sheet
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)
source: myfinsight.com